AnovaOS Network Powered Patient Registry
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Infectious Disease, Neoplasms, Diseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89), Endocrine, Nutritional and Metabolic Diseases (E00-E89). Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The objective of this study is the development, implementation and management of a registry of patient data that captures clinically meaningful, real-world, data on the diagnosis, nature, course of infection, treatment(s) and outcomes in patients with complex disease globally.
Detailed description
The AnovaOS™ Network Powered Patient Registry may be used to inform the development and conduct of clinical trials and observational studies designed to better understand, prevent, diagnose, treat, ameliorate or cure disease. The AnovaOS™ Network Powered Patient Registry may additionally be used to expedite identification and recruitment of participants for clinical trials of promising therapeutics and observational studies.
Primary outcome measures
- Assess Natural history [Time frame: 5 years]
- Assess Clinical, Cost and/or Comparative Effectiveness [Time frame: 5 years]
- Assess Safety [Time frame: 5 years]
- Measuring and/or Improving Quality of Care [Time frame: 5 years]
Eligibility criteria
Inclusion criteria
- 18 years old or older;
- Confirmed positive diagnosis of disease, condition or disorder. This will be self-reported or reported by the patient's provider, advocacy group or other patient representative;
- Laboratory or other independent means of confirmation is not required but may be confirmed in clinical trials;
- Able to understand and willing to sign the informed consent document; or whose legal representative has given consent to participate in the research per state and Federal requirements;
- Willing and able to complete the registry questions or have the instrument(s) completed by an informed proxy;
- Anticipated additional follow up with the registry once per year.
Exclusion criteria
- Subjects who do not meet the inclusion criteria for the study;
- Subjects who are unable to understand the protocol or unable to provide legally effective informed consent
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Cohort
Study locations
United States · 1 center
- Anova Enterprises, Inc. — Arlington Heights
Identifiers
NCT: NCT05013944 · ANOVA-001-NPPR